11 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Electrode Pad

FDA 510(k)
FDA Class 2 ·Neurology

ELMED

FDA UDI
ELMED INCORPORATED·00842180158986·MULTI - FLEX HANDREST, ATTACHES TO SHORT COUPLER

Millennium

FDA UDI
Avalign Technologies, Inc.·00190776190996·Handrest Attaches to Short Coupler

Tiger Shark System

FDA UDI
Choice Spine, LP·00840996166089·TIGER SHARK,STERILE,STR,9X24X15,12 DEG

MiniSPC Button

FDA UDI
APPLIED MEDICAL TECHNOLOGY, INC.·00842071152673·24F x 1.5cm MiniSPC Low Profile Suprapubic Cath...

VISIONAIRE UK Patient Matched Cutting Guides

FDA 510(k)
FDA Class 2 ·Orthopedic

NONABSORBABLE (POLYETHYLENE TEREPHTHALATE) SURGICAL SUTURE

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

LUMAX 340 DR-T

FDA Adverse Event
Injury ·BIOTRONIK GMBH & CO.·Product code MRM·November 20, 2008

R SERIES DEFIBRILLATOR

FDA Adverse Event
Malfunction ·ZOLL MEDICAL CORPORATION·Product code MKJ·August 9, 2011

LOCKING SCREWS, CROSS-PIN, DIAM.2.0X14MM, (5/PACKAGE)

FDA Adverse Event
Malfunction ·STRYKER OSTEOSYNTHESIS-FREIBURG·Product code JEY·July 22, 2013

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014